NCT01224353View on ClinicalTrials.gov

Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

July 31, 2011

Conditions
Diabetics
Interventions
DRUG

lipoic acid

Tablet, 600mg, for oral use, 30 min before breakfast, once daily for 6 weeks

OTHER

Placebo

Tablet, placebo, 1-week single-blind placebo treatment then, 30 min before breakfast, once daily for 6 weeks

Trial Locations (5)

210029

Jiangsu Provincial People's Hospital, Nanjing

214002

Wuxi No.2 People's Hospital, Wuxi

215004

The Second Affiliated Hospital of Soochow University, Suzhou

215006

The First Affiliated Hospital of Soochow University, Suzhou

226001

Affiliated Hospital of Nantong University, Nantong

Sponsors
All Listed Sponsors
lead

NovaMed Pharmaceuticals Inc.

INDUSTRY

NCT01224353 - Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy | Biotech Hunter | Biotech Hunter